Abstract
Among all organs in the human body, the liver is the largest and carries out the greatest number of functions. The liver’s important and multiple activities impact all body systems, including the nervous system. The relationship between the liver and the brain has been known for centuries (Frerichs 1860; Lewis and Howdle 2003; Tarter et al. 1989; Wilson 1912). Patients with hepatic dysfunction frequently experience neuropsychiatric syndromes, of which the most well known is hepatic encephalopathy (Ferenci et al 2002).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bakulin, I., Pasechnikov, V., Varlamicheva, A., & Sannikova, I. (2014). NS3 protease inhibitors for treatment of chronic hepatitis C: Efficacy and safety. World Journal of Hepatology, 6, 326–339.
Bonkovsky, H., & Mehta, S. (2001). Hepatitis C: A review and update. Journal of the American Academy of Dermatology, 44, 159–182.
Collie, A. (2005). Cognition in liver disease. Liver International, 25, 1–8.
Crone, C., & Gabriel, G. M. (2003). Comprehensive review of hepatitis C for psychiatrists: Risks, screening, diagnosis, treatment and interferon-based complications. Journal of Psychiatric Practice, 9, 93–110.
Crone, C. C., Gabriel, G. M., & Di Martini, A. (2006). An overview of psychiatric issues in liver disease for the consultation-liaison psychiatrist. Psychosomatics, 47, 188–205.
Desmond, C. P., Roberts, S. K., Dudley, F., Mitchell, J., Day, C., Nguyen, S., et al. (2006). Sustained virologic response rates and durability of the response to interferon-based therapies in hepatitis C patients treated in the clinical setting. Journal of Viral Hepatitis, 13, 311–315.
Doi, F., Kakizaki, S., Takagi, H., Murakami, M., Sohara, N., Otsuka, T., et al. (2005). Long term outcome of interferon-(alpha)-induced autoimmune thyroid disorders in chronic hepatitis C. Liver International, 25, 242–246.
Farrell, G. C. (2003). Nonalcoholic steatohepatitis: What is it, and why is it important in the Asia-Pacific region? Journal of Gastroenterology and Hepatology, 18, 124–138.
Ferenci, P., Lockwood, A., Mullen, K., Tarter, R., Weissenborn, K., & Blei, A. T. (2002). Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congress of Gastroenterology, Vienna, 1998. Hepatology, 35, 715–721.
Fontana, R. J., Bieliauskas, A., Back-Madruga, C., Linday, K. L., Kronful, Z., Lok, A. S., et al. (2005). Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial. Jounal of Hepatology, 43, 614–622.
Forton, D. M., Allsop, J. M., Cox, I. J., Hamilton, G., Wesnes, K., Thomas, H. C., et al. (2005). A review of cognitive impairment and cerebral metabolity abnormalities in patients with hepatitis C infection. AIDS, 19(Suppl), S53–S63.
Forton, D. M., Thomas, H. C., Murphy, C. A., Assop, J. M., Foster, B. R., Main, J., et al. (2002). Hepatitis C and cognitive impairments in a cohort of patients with mild liver disease. Hepatology, 35, 433–439.
Frerichs, F. T. (1860). A clinical treatise on diseases of the liver by Dr. Friedrich Theodor Frerichs; translated by Charles Murchison. London. The New Sydenham Society, 1860, 193–246.
Hensley, D. A., & Withers, N. W. (2003). Addiction psychiatric assessment of veterans with chronic hepatitis C. Journal of Psychosomatic Research, 55, 121.
Hensley, D. A., Withers, N. W., & Spira, J. (2003). Aggression, depression, anxiety and quality of life in veterans with chronic hepatitis C. Journal of Psychosomatics, 55, 121–122.
Hilsabeck, R. C. (2003). Neurocognitive changes in chronic liver disease. Journal of Psychosomatic Research, 55, 121.
Hilsabeck, R. C., & Malek-Ahmadi, P. I. (2004). Neurobehavioral correlates of chronic hepatitis C. Journal of Psychopathology and Behavioral Assessment, 26, 203–210.
Hilsabeck, R., Perry, W., & Hassanein, T. I. (2002). Neuropsychologiccal impairments in patients with chronic hepatitis C. Hepatology, 35, 440–446.
Hilsabeck, R. C., Withers, N. W., & Wetter, S. (2003). Neuropsychiatric changes after liver transplantation. Journal of Psychosomatic Research, 55, 116.
Klos, K. J., Ashkog, J. E., Josephs, K. A., Fealey, R. D., Cowl, C. R., & Kumar, N. (2005). Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: Probably manganese toxicity. Archives of Neurology, 62, 1385–1390.
Kramer, L., Bauer, E., Gendo, A., Funk, G., Madl, C., Pidlich, J., et al. (2002). Neurophysiological evidence of cognitive impairment in patients without hepatic encephalopathy after transjugular intrahepatic portosystemic shunts. American Journal of Gastroenterology, 97, 162–166.
Kraus, M. R., Schafer, A., Faller, H., Csef, H., & Scheurlen, M. (2003). Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy. Journal of Clinical Psychiatry, 64, 708–714.
Kraus, M. R., Shafer, A., Wissman, S., Reimer, P., & Scheurlen, M. (2005). Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin. Clinical Pharmacology & Therapeutics, 77, 90–100.
Lewis, M., & Howdle, P. D. (2003). The neurology of liver failure. QJM: An International Journal of Medicine, 96, 623–633.
Lieber, C. S. (2005). Pathogenesis and treatment of alcoholic liver disease: Progress in the last 50 years. Roczniki Akademii Medycznej w Białymstoku, 50, 7–20.
McCullough, A. J. (2002). Update on nonalcoholic liver disease. Journal of Clinical Gastroenterology, 34, 255–262.
McDonnell, S. M., Preston, B. L., Jewell, S. A., Barton, J. C., Edwards, C. Q., Adams, P. C., et al. (1999). A survey of 2,851 patients with hemochromatosis: Symptoms and response to treatment. American Journal of Medicine, 106, 619–624.
Murphy, S. L., Xu, J. & Kochanek, K. D. (2013). Deaths: Final data for 2010. National Vital Statistics Reports, 61: 1. Retrieved from http://www.cdc.gov/nchs/data/nvsr/nvsr61/nvsr61_04.pdf.
O’Carroll, R. E., Couston, M., Cossar, J., Masterton, G., & Hayes, P. C. (2003). Psychological outcome and quality of life following liver transplantation: A prospective, national, single-center study. Liver Transplantation, 9, 712–720.
Pantiga, C., Rodrigo, L. R., Cuesta, M., Lopez, L., & Arias, J. L. (2003). Cognitive deficits in patients with hepatic cirrhosis and in liver transplant recipients. Journal of Neuropsychiatry &Clinical Neuroscience, 15, 84–89.
Raison, C. L., Demetrashvili, M., Capuron, L., & Miller, A. (2005). Neuropsychiatric adverse events of interferon-(alpha): Recognition and treatment. CNS Drugs, 19, 105–123.
Rambaldi, A., Jacobs, B. P., Iaquinto, G., & Gluud, C. (2005). Milk thistle for alcoholic and/or hepatitis B or C liver disease. A systematic Cochrane hepatobiliary group review with meta analysis of randomized clinical trials. American Journal of Gastroenterology, 100, 2583–2591.
Reichenberg, A., Gorman, J., & Dieterich, D. (2005). Interferon-induced depression and cognitive impairment in hepatitis C patients: A 72 weeks prospective study. AIDS, 19(Suppl), S174–S178.
Reimer, J., Backmund, M., & Haasen, C. (2005). New psychiatric and psychological aspects of diagnosis and treatment of hepatitis C and relevance for opiate dependence. Current Opinion in Psychiatry, 18, 678–683.
Reuben, A. (2006). Alcohol and the liver. Current Opinion in Gastroenterology, 22, 263–271.
Sorrell, J. H., Zolnikov, B. J., Sharma, A., & Jinnai, I. (2006). Cognitive impairment in people diagnosed with end-stage liver disease evaluated for liver transplantation. Psychiatry & Clinical Neurosciences, 60, 174–181.
Tarter, R. E., Edwards, K. L., & Van Thiel, D. (1989). Neuropsychological dysfunction due to liver disease (Chapter 4). In R. E. Tarter, D. H. Van Thiel, & K. L. Edwards (Eds.), Medical neuropsychology (pp. 95–97). New York: Plenum Press.
Walton, N. W., & Bowden, S. C. (1997). Does liver dysfunction explain neuropsychological status in recently detoxified alcoholic-dependent clients? Alcohol, 32, 287–295.
Wessely, S., & Pariante, C. (2002). Fatigue, depression and chronic hepatitis C infection. Psychological Medicine, 32, 1–10.
Wilson, S. A. K. (1912). Progressive lenticular degeneration. A familial nervous disease associated with cirrhosis of the liver. Brain, 34, 295–307.
Withers, N. W. (2001). Deceptions in Addiction Psychiatry. American Journal of Forensic Psychiatry, 22, 7–26.
Withers, N. W. (2003). Aggression induced by interferon alfa-2b during long-term therapy for chronic hepatitis C. Journal of Neuropsychiatry & Clinical Neurosciences, 15, 259.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Hoyle Leigh & Jon Streltzer
About this chapter
Cite this chapter
Withers, N.W. (2015). The Liver-Impaired Patient. In: Leigh, H., Streltzer, J. (eds) Handbook of Consultation-Liaison Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-319-11005-9_30
Download citation
DOI: https://doi.org/10.1007/978-3-319-11005-9_30
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-11004-2
Online ISBN: 978-3-319-11005-9
eBook Packages: MedicineMedicine (R0)